Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Zehao Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shaoxing People's Hospital, 568 Zhongxing North Road, Shaoxing 312000, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Adenosine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, Medical and Health Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
N6-methyladenosine is the most common modification of eukaryotic RNA. N6-methyladenosine participates in RNA splicing, nuclear export, translation, and degradation through regulation by methyltransferases, methylation readers, and demethylases, affecting messenger RNA stability and translation efficiency. Through the dynamic and reversible regulatory network composed of “writers, erasers, and readers,” N6-methyladenosine modification plays a unique role in the process of hematopoiesis. Acute myeloid leukemia is a heterogeneous disease characterized by malignant proliferation of hematopoietic stem cells/progenitor cells. Many studies have shown that N6-methyladenosine–related proteins are abnormally expressed in acute myeloid leukemia and play an important role in the occurrence and development of acute myeloid leukemia, acting as carcinogenic or anticancer factors. Here, we describe the mechanisms of action of reversing N6-methyladenosine modification in hematopoiesis and acute myeloid leukemia occurrence and progression to provide a basis for further research on the role of N6-methyladenosine methylation and its regulatory factors in normal hematopoiesis and acute myeloid leukemia, to ultimately estimate its potential clinical value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Shaoxing People's Hospital, 568 Zhongxing North Road, Shaoxing 312000, China.
Förderung
- Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
- Medical and Health Science and Technology Project of Zhejiang Province
Zitieren
APA
Fang, Z., Ding, H., Han, J., Fu, L., Jin, J., & Feng, W. (2024). Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae106
Vancouver
Fang Z, Ding H, Han J, Fu L, Jin J, Feng W. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae106
BibTeX
@article{Fang2024,
author = {Fang, Zehao and Ding, Hanyi and Han, Jiongping and Fu, Leihua and Jin, Jing and Feng, Weiying},
title = {Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae106}
}
EUVIMED